SCHEMBL844923

SCHEMBL844923

CC(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)Cc3ccncc3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
ITGB1 P05556 4/20 0.43
ITGA4 P13612 4/20 0.43
NPC1 O15118 1/20 0.42
HCRTR1 O43613 2/20 0.41
HCRTR2 O43614 2/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MAPK10 P53779 1/20 0.41
GLA P06280 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TRPV1 Q8NER1 1/20 0.41
GAA P10253 1/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845164 0.95 ALDH1A1 (0.44) ALDH1A1ITGB1ITGA4NPC1HCRTR1
SCHEMBL845723 0.91 ALDH1A1 (0.51) ALDH1A1ITGB1ITGA4HCRTR1HCRTR2
SCHEMBL845408 0.90 ALDH1A1 (0.54) ALDH1A1ITGB1ITGA4HCRTR1HCRTR2
SCHEMBL845154 0.90 ALDH1A1 (0.54) ALDH1A1ITGB1ITGA4HCRTR1HCRTR2
SCHEMBL845401 0.89 ALDH1A1 (0.45) ALDH1A1ITGB1ITGA4HCRTR1HCRTR2
SCHEMBL845111 0.84 ALDH1A1 (0.56) ALDH1A1ITGB1ITGA4HCRTR1HCRTR2
SCHEMBL845205 0.84 ALDH1A1 (0.56) ALDH1A1ITGB1ITGA4HCRTR1HCRTR2
SCHEMBL15116912 0.84 ALDH1A1 (0.56) ALDH1A1ITGB1ITGA4HCRTR1HCRTR2
SCHEMBL845226 0.84 ALDH1A1 (0.56) ALDH1A1ITGB1ITGA4HCRTR1HCRTR2
SCHEMBL13272444 0.84 ALDH1A1 (0.56) ALDH1A1ITGB1ITGA4HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed